- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01543360
Comparison of Axillary Versus Subclavian Vein Strategies for Central Venous Catheterization Under Continuous Ultrasound Guidance
March 25, 2015 updated by: Centre Hospitalier Universitaire de Nīmes
Comparison of Axillary Versus Subclavian Vein Strategies for Central Venous Catheterization Under Continuous Ultrasound Guidance: a Prospective, Randomized, Non-inferiority Study
The main objective of this study is to compare the rate of successful establishment of a central venous catheter in the first two attempts of ultrasound-guided puncture between two techniques: (1) a subclavian technique versus (2) an axillary technique.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The secondary objectives of this study are to compare the following between the two techniques:
- the success rate of the establishment of a central venous catheter
- the success rate of establishment of a central venous catheter at the first attempt at venipuncture
- for non-failures (eg, a catheter is placed in the first four trys), time to cannulation
- the presence / absence of the following complications:
- arterial puncture (yes / no)
- pneumothorax (yes / no)
- hemothorax (yes / no)
- hematoma (yes / no)
- nerve injury (yes / no)
- aberrant course (yes / no)
The reasons catheter placement failures will also be described.
Study Type
Interventional
Enrollment (Actual)
132
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gard
-
Nîmes Cedex 09, Gard, France, 30029
- CHU de Nimes - Hopital Universitaire Caremeau
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient is available for 24 hours of follow-up
- Patient requiring the establishment of a central venous catheter
Exclusion Criteria:
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The patient is pregnant, parturient, or breastfeeding
- Patient has a body mass index < 15 or > 40
- Congenital or acquired anatomical deformity (radiation therapy, trauma, surgery) of the axillary and/or subclavian regions
- Bleeding disorder (platelets < 50,000, prothrombine < 50%, activated cephaline time > 2 times the control value)
- Severe hypoxemia defined by a ratio PaO2 / FIO2 < 100
- Infection of the puncture area
- Known thrombosis of the subclavian or axillary veins
- Scheduled length of hospitalization less than 24 hours
- Agitated or non-cooperative patient
- The patient has already been included in this study
- subclavian and axillary veins are not simultaneously echogenic on one or both sides (left and right).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Axillary strategy
The first two attempts at central venous catheterization will be performed via the distal approach (axillary vein).
The third and fourth attempts at central venous catheterization will be performed by the medial approach (subclavian vein).
|
The first two attempts at central venous catheterization will be performed via the distal approach (axillary vein).
The third and fourth attempts at central venous catheterization will be performed by the medial approach (subclavian vein).
The same puncture material/devices will be used in both arms of the study.
|
Active Comparator: Subclavian strategy
The first two attempts at central venous catheterization will be performed by the medial approach (subclavian vein).
The third and fourth attempts at central venous catheterization will be performed by the distal approach (axillary vein).
|
The first two attempts at central venous catheterization will be performed by the medial approach (subclavian vein).
The third and fourth attempts at central venous catheterization will be performed by the distal approach (axillary vein).
The same puncture material/devices will be used in both arms of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Central venous catheter established within first 2 puncture attempts
Time Frame: approximately 3 minutes
|
yes/no
|
approximately 3 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Central venous catheter established upon first punction attempt
Time Frame: approximately 3 minutes
|
yes/no
|
approximately 3 minutes
|
Establishment of a central venous catheter
Time Frame: approximately 3 minutes
|
yes/no
|
approximately 3 minutes
|
The time necessary for the establishment of a central venous catheter
Time Frame: approximately 3 minutes
|
For non-failures (ie establishment of a central venous catheter within 4 puncture attempts), the number of minutes necessary for the establishment of a central venous catheter
|
approximately 3 minutes
|
The time necessary for the establishment of a central venous catheter
Time Frame: approximately 3 minutes
|
all cases, in minutes
|
approximately 3 minutes
|
presence/absence of complications
Time Frame: Day 1
|
arterial puncture (yes / no), pneumothorax (yes / no), hemothorax (yes / no), hematoma (yes / no), nerve injury (yes / no), aberrant course (yes / no)
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jean Yves Lefrant, MD PhD, Centre Hospitalier Universitaire de Nîmes
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
February 20, 2012
First Submitted That Met QC Criteria
March 2, 2012
First Posted (Estimate)
March 5, 2012
Study Record Updates
Last Update Posted (Estimate)
March 26, 2015
Last Update Submitted That Met QC Criteria
March 25, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- LOCAL/2011/JYL-GB-01
- 2011-A01353-38 (Other Identifier: RCB number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Venous Catheterization
-
Qilu Hospital of Shandong UniversityUnknownCatheterization, Peripheral | Catheterization, Central VenousChina
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterNot yet recruitingCentral Venous CatheterizationKorea, Republic of
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterUnknownCentral Venous Catheterization
-
University of PittsburghNational Institutes of Health (NIH)CompletedCatheterization, Central VenousUnited States
-
Abant Izzet Baysal UniversityRecruitingCentral Venous CatheterizationTurkey
-
Aga Khan University Hospital, PakistanCompleted
-
University Tunis El ManarCompletedCentral Venous Catheterization
-
Seoul National University HospitalCompletedCatheterization, Central VenousKorea, Republic of
-
Seoul National University HospitalUnknownCatheterization, Central VenousKorea, Republic of
-
Seoul National University HospitalCompletedCentral Venous CatheterizationKorea, Republic of
Clinical Trials on Axillary strategy
-
University Hospital, LinkoepingRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Breast Carcinoma Metastatic in Lymph Node | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7United States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Medipol UniversityRecruitingBreast Cancer | Breast Neoplasms | Breast Cancer FemaleTurkey
-
University Hospital A CoruñaComplejo Hospitalario Universitario de Vigo; Complejo Hospitalario Universitario... and other collaboratorsRecruiting
-
KK Women's and Children's HospitalRecruitingBreast Cancer | Recurrent DiseaseSingapore
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedCarcinoma, Ductal, Breast | Female Breast NeoplasmsItaly
-
University Hospitals of Derby and Burton NHS Foundation...RecruitingBreast Cancer | Sentinel Lymph Node | Neoplasm, BreastUnited Kingdom
-
Institut Paoli-CalmettesActive, not recruitingInvasive Breast CancerFrance
-
University Hospital of FerraraCompletedArrhythmias, Cardiac | Implantable Defibrillator User | Vascular Access Complication | Venous Puncture | Pacemaker Complication | Fluoroscopy; Adverse EffectItaly